CIK 0001737953
- Non-accelerated filer
- Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822082553
- Phone
- +1 781-222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,294,810
- in 6 filings
Net −$2,294,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-16 | Coffin Robert Director | Sale | −11,464 | $6.47 | $74K | 1,821,872 |
| 2023-05-16 | Coffin Robert President & Chief R&D Officer | Sale | −7,861 | $18.05 | $142K | 1,833,336 |
| 2023-04-01 | Coffin Robert President & Chief R&D Officer | Grant or award | +45,000 | 1,841,197 | ||
| 2023-04-01 | Coffin Robert President & Chief R&D Officer | Grant or award · Employee Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2022-05-16 | Coffin Robert President & Chief R&D Officer | Sale | −5,737 | $14.59 | $84K | 1,796,197 |
| 2022-04-01 | Coffin Robert President & Chief R&D Officer | Grant or award | +26,250 | 1,801,934 | ||
| 2022-04-01 | Coffin Robert President & Chief R&D Officer | Grant or award · Employee Stock Option (right to buy) | +39,375 | 39,375 | ||
| 2021-07-02 | Coffin Robert President & Chief R&D Officer | Sale | −7,810 | $40.04 | $313K | 1,775,684 |
| 2021-06-29 | Coffin Robert President & Chief R&D Officer | Sale | −22,826 | $40.05 | $914K | 1,783,494 |
| 2021-06-28 | Coffin Robert President & Chief R&D Officer | Sale | −14,663 | $40.04 | $587K | 1,806,320 |
| 2021-04-01 | Coffin Robert President & Chief R&D Officer | Grant or award | +76,865 | 1,820,983 | ||
| 2021-04-01 | Coffin Robert President & Chief R&D Officer | Grant or award · Employee Stock Option (right to buy) | +115,300 | 115,300 | ||
| 2021-01-22 | Coffin Robert President & Chief R&D Officer | Sale | −30,197 | $44.87 | $1.4M | 1,773,921 |
| 2021-01-22 | Coffin Robert President & Chief R&D Officer | Sale | −29,803 | $43.99 | $1.3M | 1,744,118 |
| 2020-12-22 | Coffin Robert President & Chief R&D Officer | Sale | −220,000 | $40.04 | $8.8M | 1,804,118 |
| 2020-07-09 | Coffin Robert President & Chief R&D Officer | Sale | −145,500 | $22.32 | $3.2M | 2,048,368 |
| 2020-07-09 | Coffin Robert President & Chief R&D Officer | Sale | −24,250 | $21.02 | $510K | 2,024,118 |
| 2020-04-01 | Coffin Robert Pres & Chief Res & Dev Officer | Grant or award · Employee Stock Option (right to buy) | +265,000 | 265,000 | ||
| 2020-02-20 | Coffin Robert Pres & Chief Res & Dev Officer | Sale | −24,250 | $17.04 | $413K | 2,193,868 |
| 2020-02-12 | Coffin Robert Pres & Chief Res & Dev Officer | Sale | −24,250 | $17.04 | $413K | 2,242,368 |
Page 1 of 2 · 29 trades